BioSpace News Archive

Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study

Entheon ID(TM) Clinical Study to Assess the Effect of Ketamine on Neurological Activity as Measured by EEG.

November 10, 2021
·
5 min read
BioMark Recognizes and Supports the Lung Cancer Awareness Month

There are fundamental strides being made in both the early diagnosis and more effective therapeutic intervention that will better smooth the treatment journey for patients.

November 10, 2021
·
4 min read
Biotech Bay

Biotricity Delivers Bioheart, A Groundbreaking Consumer Heart Monitor

Biotricity, Inc. (NASDAQ:BTCY), a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions, today announced the availability of Bioheart, a direct-to-consumer heart monitor that offers the same continuous heart monitoring technology used by physicians.

November 10, 2021
·
7 min read
Drug Development

Gain Therapeutics, Inc. Announces Breakthrough Pre-Clinical Data of Novel Small Molecules for the Treatment of Parkinson’s Disease and Gaucher Disease

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company directly addressing the urgent need for effective neurodegenerative therapies, today announced data from the Company’s study conducted at the University of Maryland School of Medicine (UMSOM).

November 10, 2021
·
11 min read
Drug Development

EIP Pharma announces that final results of the AscenD-LB phase 2 clinical study demonstrates neflamapimod has disease-modifying potential in dementia with Lewy Bodies

EIP Pharma Inc., announces that the final results of the AscenD-LB phase 2 clinical study of their oral investigational drug, neflamapimod, in mild-to-moderate dementia with Lewy bodies were presented today at the 14th Clinical Trials in Alzheimer’s Disease (CTAD) meeting.

November 10, 2021
·
7 min read
BioForest

Athira Pharma Presents Overview and Update from ACT-AD and LIFT-AD Trials of ATH-1017 in mild-to-moderate Alzheimer’s Disease at CTAD Conference

Athira Pharma, Inc. today announced that Hans Moebius, M.D., Ph.D., Chief Medical Officer at Athira, presented an overview and updates from two ongoing late-stage clinical trials (ACT-AD and LIFT-AD) with Athira’s lead development candidate ATH-1017 in mild-to-moderate Alzheimer’s disease

November 10, 2021
·
8 min read
Pfizer tops the CNS Summit Innovation Index

The fifth annual CNS Summit Innovation Index, compiled by IDEA Pharma, sees Pfizer top the industry.

November 10, 2021
·
2 min read
Winners of the 2021 CPhI Pharma Awards have now been announced

CPhI Worldwide announces the winners of the 18th edition of the CPhI Pharma Awards, hosted live in Milan, with winners spanning some 10 distinct categories.

November 10, 2021
·
4 min read
Business

Yamo Pharmaceuticals Receives Investment from Autism Impact Fund to Support Phase 2 Study of L1-79 in Autism Spectrum Disorder

Yamo Pharmaceuticals, LLC announced that The Autism Impact Fund has made a capital investment in Yamo to support a Phase 2 study of L1-79 in adolescents and adults with ASD.

November 10, 2021
·
3 min read
Biotech Bay

Biomea Fusion to Participate in Two Upcoming Investor Conferences

Biomea Fusion, Inc. today announced that Thomas Butler, Chief Executive Officer and Chairman of the Board, will participate in two upcoming virtual conferences.

November 10, 2021
·
2 min read